dr. nadler discusses the impower131 study in squamous nsclc
Published 5 years ago • 120 plays • Length 1:42Download video MP4
Download video MP3
Similar videos
-
1:21
dr. nadler on the impact of immunotherapy in squamous nsclc
-
1:00
dr. nadler discusses role of pd-l1 in squamous nsclc
-
2:11
dr. jotte on the impower131 findings in squamous nsclc
-
2:09
dr. subramanian on the impower131 trial in squamous nsclc
-
2:12
expanding the nsclc armamentarium: impower131
-
1:31
dr. kris on search for biomarkers in advanced squamous nsclc
-
0:54
dr. bestvina on the keynote-407 trial in squamous nsclc
-
8:10
impower131: role for carbo/nab-paclitaxel/atezolizumab combo for adv. squamous nsclc? (bmic-041)
-
4:52
the keynote-407 trial in metastatic squamous nsclc
-
6:14
optimal chemotherapy for squamous nsclc
-
1:33
dr. patel on treatment considerations in advanced squamous nsclc
-
1:40
dr. socinski on immunotherapy approaches in squamous nsclc
-
5:42
role of i/o with chemotherapy in advanced squamous nsclc
-
3:23
treatment options for relapsed squamous cell lung cancer
-
9:15
chemo/immunotherapy in advanced squamous nsclc: what is the impact of impower131? (bmic-026)
-
1:05
dr. brahmer on the impower150 trial in nsclc
-
5:10
the role of immunotherapy in squamous nsclc
-
1:00
dr. raez on the keynote-407 trial in squamous cell carcinoma of the lung
-
5:28
the ever-evolving treatment paradigm for nsclc